| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
| L | | IP | | | Kapanol 200 mg | 50 | 92.36 | 116.85 | 10 % | | Delayed release capsules: Morphini Sulfas Pentahydricus 200 mg | Lipomed AG | A+ / SL | FB | | G |  |
| L | | IP | | | Kapanol 200 mg | 60 | 110.83 | 136.95 | 10 % | | Delayed release capsules: Morphini Sulfas Pentahydricus 200 mg | Lipomed AG | A+ / SL | FB | | G | |
| | | IP | | | Kapanol 10 mg | 28 | PR | PR | k.A. | | Delayed release capsules: Morphini Sulfas Pentahydricus 10 mg | Lipomed AG | A+ | FB | | G | |
| | | IP | | | Kapanol 10 mg | 28 | PR | PR | k.A. | | Delayed release capsules: Morphini Sulfas Pentahydricus 10 mg | Lipomed AG | A+ | FB | | G | |
| | | IP | CI | | Kapanol 20 mg - T | 60 | PR | PR | k.A. | | Delayed release capsules: Morphini Sulfas Pentahydricus 20 mg | Lipomed AG | A+ | FB | | G | |
| | | IP | CI | | Kapanol 50 mg - T | 60 | PR | PR | k.A. | | Delayed release capsules: Morphini Sulfas Pentahydricus 50 mg | Lipomed AG | A+ | FB | | G | |
| | | IP | CI | | Kapanol 100 mg | 60 | PR | PR | k.A. | | Delayed release capsules: Morphini Sulfas Pentahydricus 100 mg | Lipomed AG | A+ | FB | | G | |
| | | IP | CI | | Kapanol 100 mg | 100 | PR | PR | k.A. | | Delayed release capsules: Morphini Sulfas Pentahydricus 100 mg | Lipomed AG | A+ | FB | | G | |
| | | IP | | | Kapanol 200 mg | 100 | PR | PR | k.A. | | Delayed release capsules: Morphini Sulfas Pentahydricus 200 mg | Lipomed AG | A+ | FB | | G | |
| L | | IP | CI | A | Kapanol 20 mg - T | 60 Capsule(s) | 19.35 | 37.45 | 10 % | | Delayed release capsules: Morphini Sulfas Pentahydricus 20 mg | Lipomed AG | A+ / SL | FB | | G | |
| L | | IP | CI | A | Kapanol 50 mg - T | 60 Capsule(s) | 39.80 | 59.70 | 10 % | | Delayed release capsules: Morphini Sulfas Pentahydricus 50 mg | Lipomed AG | A+ / SL | FB | | G | |
| L | | IP | CI | | Kapanol 100 mg | 50 | 57.05 | 78.45 | 10 % | | Delayed release capsules: Morphini Sulfas Pentahydricus 100 mg | Lipomed AG | A+ / SL | FB | | G | |
| L | | IP | CI | A | Kapanol 100 mg | 60 Capsule(s) | 67.58 | 89.90 | 10 % | | Delayed release capsules: Morphini Sulfas Pentahydricus 100 mg | Lipomed AG | A+ / SL | FB | | G | |
| L | | IP | CI | A | Sevre-Long 30 mg | 30 Capsule(s) | 20.28 | 38.45 | 10 % | | Delayed release capsules: Morphini Sulfas Pentahydricus 30 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| L | | IP | CI | A | Sevre-Long 60 mg | 30 Capsule(s) | 33.27 | 52.60 | 10 % | | Delayed release capsules: Morphini Sulfas Pentahydricus 60 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| L | | IP | CI | A | Sevre-Long 120 mg | 30 Capsule(s) | 54.52 | 75.70 | 10 % | | Delayed release capsules: Morphini Sulfas Pentahydricus 120 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| L | | IP | CI | | Sevre-Long 120 mg | 100 Capsule(s) | 172.64 | 204.15 | 10 % | | Delayed release capsules: Morphini Sulfas Pentahydricus 120 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| L | | IP | CI | A | Sevre-Long 200 mg - T | 30 Capsule(s) | 60.92 | 82.65 | 10 % | | Delayed release capsules: Morphini Sulfas Pentahydricus 200 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| L | | IP | CI | | Sevre-Long 200 mg - T | 100 Capsule(s) | 192.89 | 226.20 | 10 % | | Delayed release capsules: Morphini Sulfas Pentahydricus 200 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | | MST Continus 10 mg | 60 Tablet(s) | 12.39 | 29.90 | 10 % | | Delayed release tablets: Morphini Sulfas Pentahydricus 10 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | ● A+ / SL | FB | | G | |
| | | IP | CI | A | MST Continus 30 mg - T | 60 Tablet(s) | 28.01 | 46.90 | 10 % | | Delayed release tablets: Morphini Sulfas Pentahydricus 30 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | A | MST Continus 60 mg - T | 30 Tablet(s) | 24.07 | 42.60 | 10 % | | Delayed release tablets: Morphini Sulfas Pentahydricus 60 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | A | MST Continus 100 mg - T | 30 Tablet(s) | 38.32 | 58.10 | 10 % | | Delayed release tablets: Morphini Sulfas Pentahydricus 100 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | A | MST Continus 200 mg - T | 30 Tablet(s) | 55.79 | 77.10 | 10 % | | Delayed release tablets: Morphini Sulfas Pentahydricus 200 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | | M-retard Zentiva 10 mg | 30 | 7.67 | 17.60 | 10 % | | Coated tablets: Morphini Hydrochloridum Trihydricum 10 mg | Helvepharm AG | A+ / SL | FB | | G | |
| | | IP | CI | | M-retard Zentiva 10 mg | 60 | 11.50 | 28.90 | 10 % | | Coated tablets: Morphini Hydrochloridum Trihydricum 10 mg | Helvepharm AG | ● A+ / SL | FB | | G | |
| | | IP | CI | | M-retard Zentiva 30 mg | 30 | 13.46 | 31.05 | 10 % | | Coated tablets: Morphini Hydrochloridum Trihydricum 30 mg | Helvepharm AG | A+ / SL | FB | | G | |
| | | IP | CI | | M-retard Zentiva 30 mg | 60 | 28.53 | 47.45 | 10 % | | Coated tablets: Morphini Hydrochloridum Trihydricum 30 mg | Helvepharm AG | A+ / SL | FB | | G | |
| | | IP | CI | | M-retard Zentiva 60 mg | 30 | 24.23 | 42.75 | 10 % | | Coated tablets: Morphini Hydrochloridum Trihydricum 60 mg | Helvepharm AG | A+ / SL | FB | | G | |
| | | IP | CI | | M-retard Zentiva 100 mg | 30 | 39.86 | 59.75 | 10 % | | Coated tablets: Morphini Hydrochloridum Trihydricum 100 mg | Helvepharm AG | A+ / SL | FB | | G | |
| | | IP | CI | | M-retard Zentiva 200 mg | 30 | 58.91 | 80.50 | 10 % | | Coated tablets: Morphini Hydrochloridum Trihydricum 200 mg | Helvepharm AG | A+ / SL | FB | | G | |
| | | IP | CI | A | Sevredol 10 mg | 20 Tablet(s) | 6.99 | 16.85 | 10 % | | Coated tablets: Morphini Sulfas Pentahydricus 10 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | | Sevredol 20 mg - T | 20 Tablet(s) | 8.78 | 25.95 | 10 % | | Coated tablets: Morphini Sulfas Pentahydricus 20 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | | Morphini HCl Streuli 10
mg/ml | 20 ml | 7.28 | 17.15 | 10 % | | Tropfen zum Einnehmen: Morphini Hydrochloridum Trihydricum 10 mg/ml | Streuli Pharma AG | ● A+ / SL | FB | | G | |
| | | IP | | | Morphini HCl Streuli 20
mg/ml | 20 ml | 12.37 | 29.85 | 10 % | | Tropfen zum Einnehmen: Morphini Hydrochloridum Trihydricum 20 mg/ml | Streuli Pharma AG | ● A+ / SL | FB | | G | |
| | | IP | | A | Morphin HCl 0,2 mg/ml
Bichsel | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum | Laboratorium Dr. G.
Bichsel AG | A+ | FB | | G | |
| | | IP | | A | Morphin HCl 0,4 mg/ml
Bichsel | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum | Laboratorium Dr. G.
Bichsel AG | A+ | FB | | G | |
| | | IP | | A | Morphin HCl 1 mg/ml
Bichsel | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 1 mg/ml | Laboratorium Dr. G.
Bichsel AG | A+ | FB | | G | |
| | | IP | | A | Morphin HCI 2 mg/ml
Bichsel | 10 Durchstechflasche(n) | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 2 mg/ml | Laboratorium Dr. G.
Bichsel AG | A+ | FB | | G | |
| | | IP | | A | Morphin HCl 10 mg/ml
Bichsel | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 10 mg/ml | Laboratorium Dr. G.
Bichsel AG | A+ | FB | | G | |
| | | IP | | A | Morphin HCl 10 mg/ml
Amino | 10 x 1 ml | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | A+ | FB | | G | |
| | | IP | | A | Morphin HCl 10 mg/ml
Amino | 100 x 1 ml | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | A+ | FB | | G | |
| | | IP | | A | Morphin HCl 20 mg/ml
Amino | 10 x 1 ml | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 20 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | A+ | FB | | G | |
| | | IP | | A | Morphin HCl 20 mg/ml
Amino | 100 x 1 ml | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 20 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | A+ | FB | | G | |
| | | IP | | A | Morphin HCl 20 mg/ml
Amino | 10 x 10 ml | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 20 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | A+ | FB | | G | |
| | | IP | | A | Morphin HCl Sintetica 2
mg/2 ml | 10 1 ampoule(s) à 2 ml | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 2mg / 2ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | A | Morphin HCl Sintetica 5
mg/0.5ml | 10 1 ampoule(s) à 0.5 ml | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 5mg / 0.5ml | Sintetica SA | ● A+ | FB | | G | |
| | | IP | | A | Morphin HCl Sintetica 10
mg/1 ml | 10 1 ampoule(s) à 1 ml | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 10 mg/ml | Sintetica SA | ● A+ | FB | | G | |
| | | IP | | A | Morphin HCl Sintetica 100
mg/10 ml | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 100mg / 10ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | A | Morphin Sulfate Sintetica
10mg/ml | Durchstechflasche(n) | PR | PR | k.A. | | Injection solution: Morphini Sulfas Pentahydricus 10 mg/ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | A | Morphin Sulfate Sintetica
50mg/ml | Durchstechflasche(n) | PR | PR | k.A. | | Injection solution: Morphini Sulfas Pentahydricus 50 mg/ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | A | Morphin Sulfate Sintetica
50mg/ml | Durchstechflasche(n) | PR | PR | k.A. | | Injection solution: Morphini Sulfas Pentahydricus 50 mg/ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | A | Morphini HCl Streuli 10
mg/ml | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 10 mg/ml | Streuli Pharma AG | ● A+ | FB | | G | |
| | | IP | | A | Morphini HCl Streuli 10
mg/ml | 100 ampoule(s) | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 10 mg/ml | Streuli Pharma AG | A+ | FB | | G | |
| | | IP | CI | | Kapanol 20 mg - T | 100 | PR | PR | k.A. | | Delayed release capsules: Morphini Sulfas Pentahydricus 20 mg | Lipomed AG | A+ | FB | | G | |
| | | IP | CI | | Kapanol 50 mg - T | 100 | 57.05 | 78.45 | k.A. | | Delayed release capsules: Morphini Sulfas Pentahydricus 50 mg | Lipomed AG | A+ | FB | | G | |
| | | IP | CI | | MST Continus 10 mg | 10 | PR | PR | k.A. | | Delayed release tablets: Morphini Sulfas Pentahydricus 10 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | IP | CI | | MST Continus 30 mg - T | 10 | PR | PR | k.A. | | Delayed release tablets: Morphini Sulfas Pentahydricus 30 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | IP | CI | | MST Continus 30 mg - T | 30 | PR | PR | k.A. | | Delayed release tablets: Morphini Sulfas Pentahydricus 30 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | IP | CI | | MST Continus 60 mg - T | 10 | PR | PR | k.A. | | Delayed release tablets: Morphini Sulfas Pentahydricus 60 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | IP | CI | | Morphini HCl Streuli 10
mg/ml | 50 ml | PR | PR | k.A. | | Tropfen zum Einnehmen: Morphini Hydrochloridum Trihydricum 10 mg/ml | Streuli Pharma AG | A+ | FB | | G | |
| | | IP | | | Morphini HCl Streuli 20
mg/ml | 50 ml | PR | PR | k.A. | | Tropfen zum Einnehmen: Morphini Hydrochloridum Trihydricum 20 mg/ml | Streuli Pharma AG | A+ | FB | | G | |
| | | IP | | | Morphin Sulfate Sintetica
1mg/ml | Sachet(s) à 100 ml | PR | PR | k.A. | | soluzione per infusione: Morphini Sulfas Pentahydricus 1 mg/ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | | Morphin Sulfate Sintetica
1mg/ml | 10 1 Sachet(s) à 100 ml | PR | PR | k.A. | | soluzione per infusione: Morphini Sulfas Pentahydricus 1 mg/ml | Sintetica SA | A+ | FB | | G | |
| | | IP | CI | | MST Continus 30 mg | 24 suppositories | 32.91 | 55.15 | k.A. | | Suppositories: Morphini Sulfas Pentahydricus 30 mg | Mundipharma Medical
Company | A | FB | | G | |
| | | IP | CI | | MST Continus 60 mg | 24 suppositories | 44.68 | 69.00 | k.A. | | Suppositories: Morphini Sulfas Pentahydricus 60 mg | Mundipharma Medical
Company | A | FB | | G | |
| | | IP | CI | | MST Continus 100 mg | 24 suppositories | 71.33 | 100.40 | k.A. | | Suppositories: Morphini Sulfas Pentahydricus 100 mg | Mundipharma Medical
Company | A | FB | | G | |
| | | IP | CI | | MST Continus 200 mg | 24 suppositories | 92.11 | 124.85 | k.A. | | Suppositories: Morphini Sulfas Pentahydricus 200 mg | Mundipharma Medical
Company | A | FB | | G | |
